The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
994
February 14, 1997
View Complete Issue         Table of Contents 2019 
More New Drugs for HIV and Associated Infections
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
More New Drugs for HIV and Associated Infections
February 14, 1997 (Issue: 994)
Four new drugs have become available in the USA for HIV infection or its complications. Nevirapine (Viramune - Roxane), intravenous cidofovir (Vistide - Gilead), and amphotericin B oral suspension (Fungizone Oral Suspension - Bristol-Myers Squibb) ...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: More New Drugs for HIV and Associated Infections
Article code: 994b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.